BLPH - Bellerophon Therapeutics, Inc.

NasdaqGM - NasdaqGM Real Time Price. Currency in USD
Currency in USD

Valuation Measures

Market Cap (intraday) 545.48M
Enterprise Value 325.86M
Trailing P/E N/A
Forward P/E 1-3.00
PEG Ratio (5 yr expected) 1-0.01
Price/Sales (ttm)N/A
Price/Book (mrq)4.40
Enterprise Value/Revenue 3N/A
Enterprise Value/EBITDA 6-1.11

Financial Highlights

Fiscal Year

Fiscal Year Ends Dec 31, 2018
Most Recent Quarter (mrq)Mar 31, 2019

Profitability

Profit Margin 0.00%
Operating Margin (ttm)0.00%

Management Effectiveness

Return on Assets (ttm)-48.88%
Return on Equity (ttm)-33.17%

Income Statement

Revenue (ttm)N/A
Revenue Per Share (ttm)N/A
Quarterly Revenue Growth (yoy)N/A
Gross Profit (ttm)N/A
EBITDA -23.37M
Net Income Avi to Common (ttm)-2.08M
Diluted EPS (ttm)-0.0350
Quarterly Earnings Growth (yoy)N/A

Balance Sheet

Total Cash (mrq)20.68M
Total Cash Per Share (mrq)0.3
Total Debt (mrq)2.43M
Total Debt/Equity (mrq)23.57
Current Ratio (mrq)2.99
Book Value Per Share (mrq)0.15

Cash Flow Statement

Operating Cash Flow (ttm)-17.39M
Levered Free Cash Flow (ttm)-10.54M

Trading Information

Stock Price History

Beta (3Y Monthly) 1.11
52-Week Change 3-75.48%
S&P500 52-Week Change 38.16%
52 Week High 32.9990
52 Week Low 30.4700
50-Day Moving Average 30.6329
200-Day Moving Average 30.7201

Share Statistics

Avg Vol (3 month) 3248.66k
Avg Vol (10 day) 3101.37k
Shares Outstanding 568.91M
Float 27.57M
% Held by Insiders 115.62%
% Held by Institutions 147.65%
Shares Short (May 31, 2019) 4814.76k
Short Ratio (May 31, 2019) 42.55
Short % of Float (May 31, 2019) 41.95%
Short % of Shares Outstanding (May 31, 2019) 41.18%
Shares Short (prior month Apr 30, 2019) 4849.57k

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 3N/A
Trailing Annual Dividend Yield 3N/A
5 Year Average Dividend Yield 4N/A
Payout Ratio 40.00%
Dividend Date 3N/A
Ex-Dividend Date 4N/A
Last Split Factor (new per old) 2N/A
Last Split Date 3N/A